trié(s) par (Pertinence décroissant(e), Titre croissant(e)) 

Article

Preclinical evaluation of theranostic strategy using nanoplatform and transferrin to target hyperactivity of cMYC in the context of non-small cell lung cancer[Compte rendu de Communication orale]

S. Martin Aubert ; M. Richard ; D. Kereselidze ; M. Evans ; B. Kuhnast ; E. Porcel ; C. Truillet |

Dans Médecine nucléaire (Vol. 47, n°2, mars 2023)

Introduction Non-small cell lung cancer affects 1.3 million people annually worldwide. The cMYC pathway regulates a large number of physiological processes and is hyperactivated in many cancers, including lung cancers. Due to the high avidity o[...]

Plus d'information... En ligne